Participation of damage-associated molecular patterns in conventional treatment of cancer

被引:0
作者
Rojo-Leon, Veronica [1 ]
Aguilar-Cazares, Dolores [1 ]
Prado-Garcia, Heriberto [1 ]
Carlos-Reyes, Angeles [1 ]
Sullivan Lopez-Gonzalez, Jose [1 ]
机构
[1] Inst Nacl Enfermedades Resp, Dept Enfermedades Cron Degenerat, Unidad Invest, Lab Canc Pulm, Mexico City 14080, DF, Mexico
来源
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | 2012年 / 64卷 / 03期
关键词
Cancer; Chemotherapy; Radiotherapy; Damage associated molecular patterns (DAMPs); Immunogenic apoptosis; Antitumor immune response; HUMAN DENDRITIC CELLS; HEAT-SHOCK PROTEINS; IMMUNE-SYSTEM; TUMOR-CELLS; ANTICANCER CHEMOTHERAPY; DYING CELLS; CALRETICULIN EXPOSURE; ATP RELEASE; T-CELLS; IN-VIVO;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cells of the innate immune system are involved in discriminating between the innocuous cell death (apoptosis) which occurs in tissues during homeostasis, and the cell death associated to tissue damage (necrosis). Recently, a new variant of apoptosis termed immunogenic apoptosis has been described. In cancer, this type of cell death has acquired great relevance. In vitro and in vivo experimental models support that radiotherapy and some chemotherapeutic drugs induce the immunogenic apoptosis of malignant cells. Dying cells express at cytoplasmic membrane or release several nuclear or intracytoplasmic molecules termed "danger signals" or damage associated molecular patterns (DAMPs). DAMPs alert the organism and play a role inducing an efficient anti-tumor immune response. In this review, the importance of cell death by immunogenic apoptosis, the cytotoxic drugs that induce this type of cell death, the biologic role of some DAMPs and their participation in the activation of the antitumor immune response, in particular in the phagocytic cell, are indicated. The goal of this information should impact in improving the participation of the immune system in the recognition and efficient elimination of the residual tumor cells and to overcome the evasion mechanisms of tumor cells. This knowledge should lead to a better control of the growth of tumors with a concomitant reduction in the tumor recurrence. Also, an increase in the survival of the cancer patients or probably their definitive cure could be reached in the future.
引用
收藏
页码:284 / 293
页数:10
相关论文
共 75 条
  • [1] Mechanisms of phagocytosis in macrophages
    Aderem, A
    Underhill, DM
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 : 593 - 623
  • [2] Pathogen recognition and innate immunity
    Akira, S
    Uematsu, S
    Takeuchi, O
    [J]. CELL, 2006, 124 (04) : 783 - 801
  • [3] Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084
  • [4] High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes
    Andersson, U
    Wang, HC
    Palmblad, K
    Aveberger, AC
    Bloom, O
    Erlandsson-Harris, H
    Janson, A
    Kokkola, R
    Zhang, MH
    Yang, H
    Tracey, KJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (04) : 565 - 570
  • [5] Carcinogenesis and aging 20 years after: Escaping horizon
    Anisimov, Vladimir N.
    [J]. MECHANISMS OF AGEING AND DEVELOPMENT, 2009, 130 (1-2) : 105 - 121
  • [6] Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies
    Apetoh, Lionel
    Tesniere, Antoine
    Ghiringhelli, Francois
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. CANCER RESEARCH, 2008, 68 (11) : 4026 - 4030
  • [7] Immunogenicity of anthracyclines: moving towards more personalized medicine
    Apetoh, Lionel
    Mignot, Grgoire
    Panaretakis, Theocharis
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) : 141 - 151
  • [8] The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Criollo, Alfredo
    Ortiz, Carla
    Lidereau, Rosette
    Mariette, Christophe
    Chaput, Nathalie
    Mira, Jean-Paul
    Delaloge, Suzette
    Andre, Fabrice
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. IMMUNOLOGICAL REVIEWS, 2007, 220 : 47 - 59
  • [9] Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Obeid, Michel
    Ortiz, Carla
    Criollo, Alfredo
    Mignot, Gregoire
    Maiuri, M. Chiara
    Ullrich, Evelyn
    Saulnier, Patrick
    Yang, Huan
    Amigorena, Sebastian
    Ryffel, Bernard
    Barrat, Franck J.
    Saftig, Paul
    Levi, Francis
    Lidereau, Rosette
    Nogues, Catherine
    Mira, Jean-Paul
    Chompret, Agnes
    Joulin, Virginie
    Clavel-Chapelon, Francoise
    Bourhis, Jean
    Andre, Fabrice
    Delaloge, Suzette
    Tursz, Thomas
    Kroemer, Guido
    Zitvogel, Laurence
    [J]. NATURE MEDICINE, 2007, 13 (09) : 1050 - 1059
  • [10] Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
    Aymeric, Laetitia
    Apetoh, Lionel
    Ghiringhelli, Francois
    Tesniere, Antoine
    Martins, Isabelle
    Kroemer, Guido
    Smyth, Mark J.
    Zitvogel, Laurence
    [J]. CANCER RESEARCH, 2010, 70 (03) : 855 - 858